APYX
Apyx Medical Inc
2.80$
-4.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 84.4% | 88.8% | 87.6% | 86.7% | 85.9% | 87.0% | 86.2% | 85.8% | 85.0% | 87.5% | 86.9% | 87.0% | |
| 37.2% | 55.1% | 52.7% | 50.0% | 46.1% | 49.0% | 51.5% | 50.4% | 43.8% | 47.5% | 49.4% | 45.2% | |
| 37.2% | 55.1% | 52.7% | 50.0% | 46.1% | 49.0% | 51.5% | 50.4% | 43.8% | 47.5% | 49.4% | 45.2% | |
| 22.3% | 17.7% | 17.7% | 19.4% | 21.5% | 23.9% | 19.4% | 19.3% | 22.7% | 25.1% | 20.2% | 22.3% | |
| 19.0% | 12.5% | 13.9% | 14.3% | 14.8% | 11.7% | 12.8% | 14.1% | 15.9% | 12.9% | 15.1% | 17.6% | |
| 43.5% | 66.0% | 71.1% | 77.2% | 81.6% | 77.9% | 82.3% | 87.2% | 89.4% | 77.8% | 79.2% | 81.8% | |
| 17.3% | 16.1% | 14.9% | 16.3% | 15.7% | 16.5% | 15.8% | 18.2% | 19.1% | 17.5% | 15.0% | 15.3% | |
| 0.6% | 0.5% | 0.5% | 0.5% | 0.6% | 0.5% | 0.6% | 0.7% | 0.7% | 0.6% | 0.7% | 0.8% | |
| 3.4% | 3.4% | 3.0% | 3.6% | 3.2% | 4.0% | 3.8% | 5.0% | 5.6% | 4.6% | 4.2% | 3.6% | |
| 15.2% | 41.9% | 47.2% | 51.4% | 55.8% | 52.3% | 56.7% | 59.1% | 60.3% | 52.1% | 55.7% | 57.8% | |
| 56.1% | 33.7% | 28.6% | 22.6% | 18.2% | 21.9% | 17.5% | 12.5% | 10.2% | 21.8% | 20.4% | 17.5% | |
| -75.4% | -68.7% | -87.7% | -104.9% | -120.7% | -120.2% | -136.4% | -147.5% | -153.1% | -133.3% | -144.8% | -154.7% | |
| 58.3% | 43.7% | 49.0% | 53.0% | 57.1% | 58.9% | 59.1% | 70.0% | 71.0% | 63.1% | 66.9% | 69.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.